MedPath

VPRIV

VPRIV

Approved
DIN Number

02357119

Drug Class

Human

Market Date

Nov 22, 2010

Company
HC

takeda canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02357119
AIG Number0152808002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D ,  Prescription
A
ATC Code
A16AB10 VELAGLUCERASE ALFA
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification44:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

VELAGLUCERASE ALFAActive
Strength: 400 UNIT / VIAL
Monograph: VELAGLUCERASE ALFA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.